All results
2 results
-
NRG-BR009: Testing the addition of chemo to SOC in breast cancer patients at high risk of recurrence
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to…
- Ages
- 18 Years - 60 Years
- Sexes
- Female
-
TREAT-MS
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the progressive phase has…
- Ages
- 18 Years - 60 Years
- Sexes
- All